Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT06507878
- Status
- Recruiting
Conditions
- Thyroid Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this clinical research study is to learn about the barriers in the real world to accessing treatments for ATC. And to learn about how patients with ATC tolerate and respond to the commercially available medications for treatment of this disease, outside of a clinical study.
Key Dates
- Start date
- Dec 5, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 1, 2032
- Completion
- Jul 1, 2034
Study Design
- Enrollment
- 459 participants (estimated)
Primary Outcome Measure
Overall Survival [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Priyanka C Iyer, MBBS(832) 291-6069
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| MD Anderson Cancer Center | Houston | Texas | 77030 |
Find similar trials in Houston, TX
By research site
Related Studies
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.PHASE1 · Recruiting · Pfizer · Fayetteville, Arkansas
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruiting · Adela, Inc · Duarte, California
- A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPHASE1 · Recruiting · Pfizer · Birmingham, Alabama
- Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TCPHASE2 · Recruiting · Massachusetts General Hospital · Washington D.C., District of Columbia